High-Throughput Immunomodulator Screening Reveals Subtype-Specific Responses in Low-Abundance Immune Cell Populations Using Scalable scRNA-seq 2260031
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.836 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Sarah Schroeder und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Understanding immune cell variability including rare populations is essential for dissecting inflammatory mechanisms and therapeutic response. However, functional screening of immunomodulators is often limited by precious sample availability and cell loss during processing.
Methods
We present a fixation-compatible combinatorial barcoding workflow optimized for low-input immune samples (< 20,000 PBMCs), enabling high-resolution profiling of rare subsets such as classical monocytes, regulatory T cells, and B-cell subtypes. This approach supports 96-condition parallel perturbation while preserving transcriptomic integrity and subtype recovery (>65% retention), even in fragile or low-abundance populations.
Results
In a screen of 88 immunomodulatory compounds in cultured PBMCs, including PDE4 inhibitors and glucocorticoids, we identified both drastic and subtle shifts in gene expression within classical monocytes, alongside pathway-specific perturbations in B and T cell compartments. Notably, compounds targeting the same pathway elicited concordant transcriptional programs, enabling comparative pharmacodynamic insights at single cell resolution.
Conclusion
This scalable low-input single-cell approach enables detailed investigation of immune cell behavior under perturbation, capturing both robust and subtle transcriptional responses across rare and abundant PBMC subsets. By accommodating limited sample availability, it supports exploration of how immunomodulators influence cell states, lineage stability, and inflammatory programs at high resolution. Such screens enable efficient discoveries of drug efficacy and detection of secondary effects, offering a powerful experimental framework for uncovering immune mechanisms, comparative pathway responses, and context-dependent variability within complex immune systems. Funding Source n/a Topic Categories Technological Innovations in Immunology (TECH)
Zitieren
APA
Schroeder, S., Kaplan, O., Tran, V., Marrujo, S., Salvino, A., Sapre, A., Dowsett, I., Sayar, Z., Koriath, A., Sova, A., Siputro, J., Geiss, G., Roco, C., & Rosenberg, A. (2026). High-Throughput Immunomodulator Screening Reveals Subtype-Specific Responses in Low-Abundance Immune Cell Populations Using Scalable scRNA-seq 2260031. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.836
Vancouver
Schroeder S, Kaplan O, Tran V, Marrujo S, Salvino A, Sapre A, et al. High-Throughput Immunomodulator Screening Reveals Subtype-Specific Responses in Low-Abundance Immune Cell Populations Using Scalable scRNA-seq 2260031. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.836
BibTeX
@article{Schroeder2026,
author = {Schroeder, Sarah and Kaplan, Olivia and Tran, Vuong and Marrujo, Simone and Salvino, Alec and Sapre, Ajay and Dowsett, Ian and Sayar, Zeynep and Koriath, Alex and Sova, Alex and Siputro, Jason and Geiss, Gary and Roco, Charles and Rosenberg, Alex},
title = {High-Throughput Immunomodulator Screening Reveals Subtype-Specific Responses in Low-Abundance Immune Cell Populations Using Scalable scRNA-seq 2260031},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.836}
}
EUVIMED